ShoimerIWrightNHaberRM. Noninfectious granulomas: a sign of an underlying immunodeficiency?J Cutan Med Surg. 2016;20(3):259-262. doi:10.1177/1203475415626085.
2.
BodemerCAuvageVMahlaouiet al. Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency. Clin Microbiol Infect. 2014;20(10):O656-O663. doi:10.1111/1469-0691.12573.
3.
PerelyginaLPlotkinSRussoP. Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2016;138(5):1436-1439. doi:10.1016/j.jaci.2016.06.030.
4.
NevenBPérotPBruneauJet al. Cutaneous and visceral chronic granulomatous disease triggered by a rubella virus vaccine strain in children with primary immunodeficiencies. Clin Infect Dis. 2017;64(1):83-86. doi:10.1093/cid/ciw675.
5.
PerelyginaLHautalaTSeppänenMAdebayoASullivanKEIcenogleJ. Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency. Antiviral Res. 2017;147:58-66. doi:10.1016/j.antiviral.2017.09.019.
